ArticleJournal of clinical medicine2021
Bleomycin for Percutaneous Sclerotherapy of Venous and Lymphatic Malformations: A Retrospective Study of Safety, Efficacy and Mid-Term Outcomes in 26 Patients.
Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Bleomycin ElectroScleroTherapy (BEST): mechanistic parallels to electrochemotherapy, experimental models, and unresolved questions.Radiology and oncology · 2026Review
- Case Report: A rare mimicker of traumatic brachial plexopathy: intramuscular venous malformation of the subscapularis muscle.Frontiers in surgery · 2026Article
- Laparoscopic intracavitary catheterization combined with bleomycin quadruple sclerotherapy for retroperitoneal lymphatic malformations: a single-center case series.Frontiers in surgery · 2026Article
- Efficacy and safety of portable ultrasound-guided pingyangmycin sclerotherapy for deep-seated oral and maxillofacial venous malformations: a retrospective observational study.Frontiers in neurology · 2026Observational
- Bleomycin sclerotherapy for venous vascular malformations of the tongue.Journal of neurointerventional surgery · 2025Article
- The Role of Bleomycin Sclerotherapy in Venous Malformation Management: A Narrative Review.Life (Basel, Switzerland) · 2025Review
- Predictive Factors for Response to Percutaneous Bleomycin in Lymphatic-Venous Malformations of the Head and Neck.Journal of clinical medicine · 2025Article
- Ultrasound-Guided Percutaneous Sclerotherapy With Bleomycin for Management of Infantile Subcutaneous Hemangioma: A Case Report.Clinical case reports · 2025Article
- Never Regret Trying Image-Guided Sclerotherapy in Orbital Low-Flow Malformation.The Indian journal of radiology & imaging · 2025Article
- CT-guided percutaneous aspiration and bleomycin sclerotherapy for symptomatic hepatic cysts: technique and three-year outcomes.Frontiers in medicine · 2025Article
- Multi-disciplinary diagnosis and management of verrucous venous malformation of the right knee: a case report.Frontiers in radiology · 2025Article
- Intralesional injection of bleomycin in the management of low flow vascular malformations: Results and factors affecting the outcome.Journal of vascular surgery. Venous and lymphatic disorders · 2024Article
- Embolic Agents: Sclerotherapy.Seminars in interventional radiology · 2024Review
- Sclerotherapy in orbital lymphangioma: A case report.Radiology case reports · 2023Article
- Contemporary management of extracranial vascular malformations.Pediatric radiology · 2023Review
- The rare complication of vascular malformations of the limb after sclerotherapy: a report of 3 cases and brief literature review.BMC pediatrics · 2023Article
- Results of interventional treatment of peripheral slow-flow malformations.CVIR endovascular · 2023Article
- Venous Malformations.Seminars in interventional radiology · 2022Review
- Editorial of Special Issue "Embolization Techniques: State of the Art and Future Perspectives".Journal of clinical medicine · 2022Article
- Sclerotherapy in Lymphatic Malformations with Intralesional Hemorrhage: A Retrospective Comparison with Non-Hemorrhagic Lymphatic Malformations.Clinical, cosmetic and investigational dermatology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous sclerotherapy is used to treat venous and lymphatic vascular malformations, which can cause significant discomfort and/or disfigurement. The purpose of this study is to describe the bleomycin sclerotherapy technique and to evaluate its clinical and radiological efficacy and safety. We retrospectively identified consecutive patients with venous malformations (VMs) and lymphatic malformations (LMs) who underwent bleomycin sclerotherapy in 2011-2020 at our institution. We collected the clinical and radiological success rates, complications and recurrences separately in the VM and LM groups. We identified 26 patients, 15 with VMs and 11 with LMs. The significant volume reductions obtained were 45% in the VM group and 76% in the LM group (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.